Frontiers in Medicine (Aug 2021)

Case Report: SARS-CoV-2 Mother-to-Child Transmission and Fetal Death Associated With Severe Placental Thromboembolism

  • Penélope Saldanha Marinho,
  • Antonio José Ledo Alves da Cunha,
  • Antonio José Ledo Alves da Cunha,
  • Leila Chimelli,
  • Elyzabeth Avvad-Portari,
  • Elyzabeth Avvad-Portari,
  • Felipe da Matta Andreiuolo,
  • Patrícia Soares de Oliveira-Szejnfeld,
  • Patrícia Soares de Oliveira-Szejnfeld,
  • Mayara Abud Mendes,
  • Ismael Carlos Gomes,
  • Ismael Carlos Gomes,
  • Letícia Rocha Q. Souza,
  • Marilia Zaluar Guimarães,
  • Marilia Zaluar Guimarães,
  • Suzan Menasce Goldman,
  • Mariana Barros Genuíno de Oliveira,
  • Stevens Rehen,
  • Stevens Rehen,
  • Joffre Amim,
  • Fernanda Tovar-Moll,
  • Fernanda Tovar-Moll,
  • Arnaldo Prata-Barbosa,
  • Arnaldo Prata-Barbosa

DOI
https://doi.org/10.3389/fmed.2021.677001
Journal volume & issue
Vol. 8

Abstract

Read online

SARS-CoV-2 infection during pregnancy is not usually associated with significant adverse effects. However, in this study, we report a fetal death associated with mild COVID-19 in a 34-week-pregnant woman. The virus was detected in the placenta and in an unprecedented way in several fetal tissues. Placental abnormalities (MRI and anatomopathological study) were consistent with intense vascular malperfusion, probably the cause of fetal death. Lung histopathology also showed signs of inflammation, which could have been a contributory factor. Monitoring inflammatory response and coagulation in high-risk pregnant women with COVID-19 may prevent unfavorable outcomes, as shown in this case.

Keywords